Observational study finds significant increase in vitamin K deficiency rates among newborns — Evidence Review
Published in JAMA Pediatrics, by researchers from Children’s Hospital of Richmond at VCU, Virginia Commonwealth University School of Medicine
Table of Contents
A new study finds a substantial rise in vitamin K deficiency and associated bleeding among U.S. infants as more parents decline the recommended newborn vitamin K injection. These findings are consistent with prior research, which shows that vitamin K prophylaxis at birth significantly reduces risk of bleeding complications in infants, and that refusal of prophylaxis increases preventable harm (1, 3, 5).
- Multiple large reviews confirm that intramuscular vitamin K at birth dramatically lowers the incidence of late vitamin K deficiency bleeding (VKDB), with studies showing much higher risk in infants who miss the shot or receive incomplete oral regimens (1, 4, 5).
- Cases of life-threatening VKDB, including intracranial hemorrhage, have been repeatedly linked to parental refusal of vitamin K in both U.S. and international studies, highlighting the preventable nature of these events (3, 5, 6).
- While oral regimens can be effective if strictly adhered to, intramuscular injection remains the most reliable method, and the trend of increasing refusal threatens the progress made in reducing VKDB over recent decades (2, 4, 5, 6).
Study Overview and Key Findings
Concerns about rising parental refusal of newborn vitamin K injections have prompted new research into the clinical consequences for infants. The latest nationwide study analyzed over 11 million U.S. infants born between 2017 and 2025, focusing on trends in vitamin K deficiency (VKD) and vitamin K deficiency bleeding (VKDB). The findings are especially relevant in the context of growing mistrust of public health recommendations, which has been linked to declining uptake of preventive interventions such as the vitamin K shot. The study not only tracked changes in diagnosis rates and shot refusal, but also explored associations with severe outcomes, including intracranial hemorrhage.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Children’s Hospital of Richmond at VCU, Virginia Commonwealth University School of Medicine |
| Journal Name | JAMA Pediatrics |
| Authors | Elizabeth R. Wolf, Evan French, Darya Shokouhi Niaki, Steven H. Woolf |
| Population | Infants aged 0 to 6 months born at 35 weeks’ gestation or later |
| Sample Size | more than 11 million infants |
| Methods | Observational Study |
| Outcome | Rates of vitamin K deficiency and associated bleeding |
| Results | VKD and VKDB rates increased by 216% and 347% from 2017 to 2025. |
Literature Review: Related Studies
To place the new findings in context, we searched the Consensus database, which contains over 200 million research papers, using targeted queries related to vitamin K deficiency and prophylaxis in infants. The following search queries were used:
- vitamin K deficiency newborns
- VKD VKDB trends 2017 to 2025
- vitamin K supplementation effects infants
Related Studies: Key Topics and Findings
| Topic | Key Findings |
|---|---|
| Why is vitamin K prophylaxis necessary for newborns? | - Newborns have low vitamin K stores, placing them at risk for VKDB, especially if exclusively breastfed (2, 4, 5, 7). - Without prophylaxis, the incidence of late VKDB is significantly higher (1, 6). |
| How effective are different vitamin K administration methods in preventing VKDB in infants? | - Intramuscular vitamin K at birth is highly effective at preventing both classic and late VKDB (1, 4, 5). - Oral regimens can be effective if completed, but compliance issues reduce efficacy (2, 4, 8). |
| What are the consequences of refusing or omitting vitamin K prophylaxis at birth? | - Parental refusal or omission leads to a measurable increase in VKDB, including severe outcomes such as intracranial hemorrhage (3, 5, 6). - Refusal is an increasing trend, especially in high-income countries (3, 6). |
| What are the challenges and alternatives to current vitamin K prophylaxis recommendations? | - Oral regimens are less reliable due to compliance issues and are not suitable for certain populations (e.g., preterm or cholestatic infants) (2, 4, 9). - Maternal supplementation can improve infant vitamin K status but is not a substitute for neonatal prophylaxis (7). |
Why is vitamin K prophylaxis necessary for newborns?
Research consistently demonstrates that newborns are at risk for vitamin K deficiency due to limited placental transfer, low stores at birth, and inadequate supply in breast milk, particularly for exclusively breastfed infants. The new study’s finding of increased VKDB as injection rates fall aligns with these established risk factors (2, 4, 5, 7). Historical and recent international surveys confirm that the absence of prophylaxis dramatically increases the risk of VKDB, leading to preventable morbidity and mortality (1, 6).
- Newborns have physiologically low vitamin K levels, making prophylaxis essential to prevent bleeding disorders (2, 4).
- Late VKDB is almost exclusively seen in infants who have not received prophylaxis (1, 6).
- Breastfed infants are at higher risk due to lower vitamin K content in human milk (2, 5, 7).
- Preterm infants are particularly vulnerable and require special prophylaxis considerations (9).
How effective are different vitamin K administration methods in preventing VKDB in infants?
Multiple studies confirm that intramuscular (IM) vitamin K administered at birth is the most effective method to prevent both classic and late VKDB (1, 4, 5). Oral regimens can also prevent VKDB, but their success hinges on strict adherence to multi-dose protocols and parental compliance (2, 4, 8). The increased rates of VKDB observed in the new study as IM injection rates decline highlight the superior reliability of the IM route.
- IM vitamin K is highly effective for both classic and late VKDB (1, 4, 5).
- Single-dose oral regimens are inferior to IM and carry higher risk (1, 4).
- Multi-dose oral regimens can be as effective as IM, but only with perfect compliance (2, 4, 8).
- No significant difference is seen between IM and oral regimens if the oral protocol is fully completed, but real-world adherence is problematic (8).
What are the consequences of refusing or omitting vitamin K prophylaxis at birth?
Parental refusal or omission of vitamin K prophylaxis is closely linked to rising rates of VKDB, including severe, sometimes fatal, complications like intracranial hemorrhage (3, 5, 6). The upward trend in refusal, as reported in the new study, mirrors findings from earlier case series and surveillance reports, which document increasing cases of preventable VKDB in infants whose parents declined prophylaxis (3, 6).
- Refusal of vitamin K at birth leads to increased VKDB and major hemorrhagic complications (3, 5).
- Intracranial bleeding and neurosurgical intervention have been required in infants with VKDB after missed prophylaxis (3).
- Parental refusal is an increasing problem in high-income settings, undermining decades of progress (5, 6).
- Most late VKDB cases occur in infants with no prophylaxis or incomplete oral regimens (6).
What are the challenges and alternatives to current vitamin K prophylaxis recommendations?
While oral vitamin K regimens provide an alternative to IM injection, their effectiveness is limited by compliance and suitability for certain infant populations (2, 4, 9). Maternal supplementation can modestly improve infant vitamin K status but is not considered a reliable substitute for direct neonatal prophylaxis (7). These challenges underscore the unique reliability of IM injection, especially as refusal rates rise.
- Oral regimens require multiple doses and high compliance, which is difficult to achieve in practice (2, 4, 8).
- Preterm, cholestatic, or otherwise ill infants may not absorb oral vitamin K effectively, making IM administration essential (4, 9).
- Maternal oral supplementation increases vitamin K in breast milk and infant serum but does not replace the need for neonatal prophylaxis (7).
- Ongoing research seeks to optimize dosing and protocols for at-risk groups (9).
Future Research Questions
Despite clear evidence supporting vitamin K prophylaxis at birth, knowledge gaps remain regarding communication strategies, alternative regimens, and optimal approaches for diverse populations. Further research is needed to address the reasons behind parental refusal, compare different prophylaxis methods, and develop interventions to increase uptake.
| Research Question | Relevance |
|---|---|
| What are the most effective strategies to improve parental acceptance of vitamin K prophylaxis in newborns? | Understanding and addressing parental concerns is critical to reversing the trend of refusal and reducing VKDB incidence (3, 5). |
| How do multi-dose oral vitamin K regimens compare to intramuscular injection for prevention of late VKDB? | Comparative effectiveness data can inform recommendations, especially in contexts where IM injection is declined or not feasible (1, 2, 4, 8). |
| What are the long-term outcomes for infants who experience vitamin K deficiency bleeding? | Long-term follow-up can clarify the true burden of VKDB and strengthen arguments for universal prophylaxis (3, 5). |
| Can maternal vitamin K supplementation safely replace neonatal prophylaxis? | Exploring alternative approaches may benefit populations with high refusal rates, but current evidence suggests supplementation is not sufficient alone (7). |
| What are the optimal vitamin K prophylaxis protocols for preterm and at-risk infants? | Preterm and at-risk infants may require tailored protocols due to absorption and metabolic differences (4, 9). |